Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRWS Holdings Regulatory News (RWS)

Share Price Information for RWS Holdings (RWS)

Share Price is delayed by 15 minutes
Get Live Data
104.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.30 (0.287%)
Market Cap: £387.87m
RWS Live PriceLast checked at - London Stock Exchange

Intraday RWS Holdings Share Chart

Share Repurchase Programme

14 Jun 2023 07:00

RNS Number : 6159C
RWS Holdings PLC
14 June 2023
 

For immediate release 14 June 2023

RWS Holdings plc

Share Repurchase Programme

As previously announced on 8 June 2023 in its half-year results for the six months ended 31 March 2023, RWS Holdings plc ("RWS" or the "Company") is today launching a share repurchase programme of up to £50 million to be executed by the Company's next Annual General Meeting, expected to be held in February 2024 (the "Repurchase Programme").

RWS will execute the Repurchase Programme in two tranches. In respect of the first tranche, RWS has today entered into a non-discretionary agreement with Numis Securities Limited ("Numis") to purchase RWS's ordinary shares of 1 pence each ("RWS Shares") for an aggregate value (excluding expenses) of up to £25 million pursuant to the Repurchase Programme (the "Initial Tranche"). Numis will act as riskless principal for the simultaneous on-sale of such RWS Shares to RWS and will make its trading decisions concerning the timing of the purchases of RWS Shares independently of and uninfluenced by RWS. Purchases of RWS Shares under the Initial Tranche will commence today and end no later than the date of the Company's next Annual General Meeting and will be carried out on the London Stock Exchange.

The second tranche of the Repurchase Programme will commence promptly once Numis has completed the Initial Tranche. For the purposes of effecting the second tranche, RWS has today entered into a non-discretionary agreement with Joh. Berenberg, Gossler & Co. KG, London Branch ("Berenberg") to purchase further RWS Shares for an aggregate value (excluding expenses) of up to £25 million (the "Second Tranche"). Berenberg will undertake the Second Tranche on the same terms as Numis and will only commence share repurchases once the Initial Tranche has been completed. Purchases under the Second Tranche will end no later than the date of the Company's next Annual General Meeting.

The aggregate purchase price of RWS Shares purchased by Numis and Berenberg under the Repurchase Agreement will not exceed £50 million (exclusive of expenses). The purpose of the Repurchase Programme is to reduce the share capital of RWS. To the extent permitted by law, all RWS Shares purchased under the Repurchase Programme will be cancelled.

The Repurchase Programme will be conducted within certain pre-set parameters, and in accordance with the general authority to repurchase shares granted by RWS's shareholders at the 2023 Annual General Meeting and with the EU Market Abuse Regulation (596/2014) (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019), the Commission Delegated Regulation (EU) 2016/1052 (as in force in the UK and as amended by the FCA's Technical Standards (Market Abuse Regulation) (EU Exit) Instrument 2019) and the AIM Rules.

The maximum number of RWS Shares which may be purchased by RWS under the Repurchase Programme is 38,946,009, which is the maximum number permitted pursuant to the authority granted by RWS's shareholders at the 2023 Annual General Meeting.

RWS will announce any market repurchases of RWS Shares no later than 7.30 a.m. on the business day following the date on which the repurchase occurred.

For further information, please contact:

RWS Holdings plc

Andrew Brode, Chairman

Ian El-Mokadem, Chief Executive Officer

Candida Davies, Chief Financial Officer

 

 

 

01753 480200

 

MHP (Financial PR Advisor)

Katie Hunt / Eleni Menikou / Catherine Chapman

 

rws@mhpc.com

020 3128 8100

07884 494112

 

Numis (Nomad & Joint Broker)

Stuart Skinner / Kevin Cruickshank / Will Baunton

 

 

 

020 7260 1000

 

Berenberg (Joint Broker)

Ben Wright / Toby Flaux / Alix Mecklenburg-Solodkoff

 

020 3207 7800

 

About RWS:

RWS Holdings plc is a unique, world-leading provider of technology-enabled language, content and intellectual property services. Through content transformation and multilingual data analysis, our combination of AI-enabled technology and human expertise helps our clients to grow by ensuring they are understood anywhere, in any language.

Our purpose is unlocking global understanding. By combining cultural understanding, client understanding and technical understanding, our services and technology assist our clients to acquire and retain customers, deliver engaging user experiences, maintain compliance and gain actionable insights into their data and content.

Over the past 20 years we've been evolving our own AI solutions as well as helping clients to explore, build and use multilingual AI applications. With 40+ AI-related patents and more than 100 peer-reviewed papers, we have the experience and expertise to support clients on their AI journey.

We work with over 80% of the world's top 100 brands, more than three-quarters of Fortune's 20 'Most Admired Companies' and almost all of the top pharmaceutical companies, investment banks, law firms and patent filers. Our client base spans Europe, Asia Pacific and North and South America. Our 65+ global locations across five continents service clients in the automotive, chemical, financial, legal, medical, pharmaceutical, technology and telecommunications sectors.

Founded in 1958, RWS is headquartered in the UK and publicly listed on AIM, the London Stock Exchange regulated market (RWS.L).

For further information, please visit: www.rws.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSNKNBPCBKDFAD
Date   Source Headline
2nd Jun 202610:17 amRNSHolding(s) in Company
1st Jun 20267:00 amRNSTotal Voting Rights
5th May 202612:23 pmRNSUpdate re Agreement to acquire Obviously Group Ltd
5th May 20267:00 amRNSAgreement in principle to acquire Obviously Group
1st May 20267:00 amRNSTotal Voting Rights
28th Apr 202612:10 pmRNSHolding(s) in Company
27th Apr 20262:48 pmRNSHolding(s) in Company
23rd Apr 20267:00 amRNSTrading Statement
1st Apr 20267:00 amRNSTotal Voting Rights
26th Mar 20263:41 pmRNSDirector/PDMR Shareholding
25th Mar 20269:15 amRNS-RRWS launches Language Weaver Pro
25th Mar 20267:00 amRNSIssue of Equity and Total Voting Rights
10th Mar 20264:40 pmRNSHolding(s) in Company
10th Mar 20264:40 pmRNSHolding(s) in Company
4th Mar 20269:37 amRNSDirector/PDMR Shareholding
2nd Mar 20267:00 amRNSTotal Voting Rights
12th Feb 202611:45 amRNSDirector/PDMR Shareholding
11th Feb 202611:44 amRNSResult of AGM
11th Feb 20267:00 amRNSAGM Statement
10th Feb 20262:00 pmRNSHolding(s) in Company
6th Feb 202612:30 pmRNSDirector/PDMR Shareholding
2nd Feb 20267:00 amRNSTotal Voting Rights
30th Jan 20263:06 pmRNSHolding(s) in Company
28th Jan 20263:24 pmRNSDirector/PDMR Shareholding
28th Jan 20263:19 pmRNSDirector/PDMR Shareholding
23rd Jan 20261:00 pmRNSDirector/PDMR Shareholding
23rd Jan 20261:00 pmRNSDirector/PDMR Shareholding
23rd Jan 20269:00 amRNSOption Exercise, Admission and Total Voting Rights
23rd Jan 20267:00 amRNSHolding(s) in Company
14th Jan 20267:00 amRNSHolding(s) in Company
8th Jan 20269:00 amRNSPublication of Annual Report and Notice of AGM
2nd Jan 20264:51 pmRNSHolding(s) in Company
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
19th Dec 20257:00 amRNSHolding(s) in Company
19th Dec 20257:00 amRNSHolding(s) in Company
12th Dec 20253:53 pmRNSHolding(s) in Company
11th Dec 20257:01 amRNSDirectorate change
11th Dec 20257:00 amRNSFinal Results
1st Dec 20257:00 amRNSTotal Voting Rights
11th Nov 20258:00 amRNSHolding(s) in Company
7th Nov 20259:00 amRNSHolding(s) in Company
3rd Nov 20257:00 amRNSTotal Voting Rights
31st Oct 20259:00 amRNSHolding(s) in Company
28th Oct 20257:00 amRNSTrading Statement
20th Oct 20253:06 pmRNSHolding(s) in Company
20th Oct 20259:05 amRNS-RHead of Media & Entertainment appointment
15th Oct 20257:00 amRNSDirectorate Change
3rd Oct 20257:00 amRNSDirectorate Change
2nd Oct 202511:38 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.